Lonza has signed two separate deals with California-based Genentech
- a move that illustrates the re-emergence of a relationship
between the two firms.
The Waters Corporation and Advion Biosciences have formed an
agreement in which the two companies intend to combine products and
offer life scientists enhanced capabilities.
Valois has made two major instrument investments that will allow it
to dramatically increase productivity as it dons the diving suit to
undertake environmental testing in its cleanrooms.
Wyeth has boosted production at the US plant it has earmarked for
closure while it is dealing with ongoing manufacturing deficiencies
in its Puerto Rico facility.
ESA Analytical introduces its latest ultra-high sensitivity
detector for fast HPLC, which provides laboratories with the
ability to monitor HPLC eluants down to miniscule detection levels.
Asterand is to make available novel research materials to be used
in the investigation of rheumatoid arthritis, osteoarthritis,
cancer and other diseases making available a range of cell material
that is currently difficult to obtain.
According to a new report, CRO's are primarily selected on their
scientific expertise and the cost/value ratio as pharmaceutical and
biotech companies look to speed up the research and development
process whilst adhering to stricter...
A survey conducted by the National Institute of Health (NIH) has
revealed a low level of job satisfaction amongst scientists
conducting research at the organisation, exacerbated by the
introduction of ethical guidelines.
Wyeth Pharmaceuticals has announced they have entered into
collaboration with Ablynx in a deal, which aims to commercialise a
class of antibody-derived therapeutic proteins targeting diseases
that include oncology and Alzheimer's...
Charles River Laboratories is the latest in a series of large
contract research organisations making acquisitions to beef up
their Phase I capacity as this market sector remains hot.
DSM Biologics, the biopharma arm of DSM group, has signed a
manufacturing deal with Japanese UMN Pharma based on the firm's
novel recombinant protein manufacturing platform.
One of the most influential medical journals, The Lancet,
has weighed into the European REACH chemicals debate, which is at
near boiling point as the draft legislation approaches its final
approval date in December.
Germany's Vetter Pharma-Fertigung has announced its plan to expand
its services by adding vial filling for lyophilised - or
freeze-dried - products to its portfolio.
Tecan release their latest platform that provides reliability and
flexibility for a range of 96-well format applications, including
washing of ELISAs, cellular assays and protein arrays, and vacuum
filtration-to-waste, such as for...
Drug manufacturers having troubles complying with the FDA?s current
Good Manufacturing Practice (cGMP) regulations, may now have the
help they need thanks to a new white paper available on the
subject.
Pharma company NovaDel has announced that the US regulators have
given the thumbs up to its oral spray for relieving and preventing
angina due to coronary artery disease.
According to a new report, drug makers are shifting to
'niche-buster' drugs in an attempt to drive future sales growth.
The niche-buster drug has become a viable alternative to the
blockbuster drug model that has served...
Ambit Biosciences has entered into a discovery and development
collaboration with pharmaceutical company Cephalon, signifying the
first time a pharma company has decided to characterise their
entire library of potential drugs based...
A new improved range of urethane-based floor systems that is
claimed to help pharma manufacturers reduce the level of bacteria
contamination in their production environment has been launched.
Rising contract research organisation (CRO) and investigator fees
are being blamed in a new report as largely contributing to the
skyrocketing cost of new drugs.
Scientists have discovered an unusual distribution of two proteins
in the lungs and airways of people with cystic fibrosis could form
the basis of a therapy that could better define the immune system's
role in cystic fibrosis.
Ground Zero Pharmaceuticals (GZP) has announced an expansion to the
services it offers enabling the expansion into more of its clients'
late-stage development programs, with the potential for creating
submissions that lead to...
Isogenica has entered into a research and licence option agreement
with UCB for the discovery of novel peptide ligands, which UCB
intends to incorporate into therapeutic products.
California's Health and Human Services (HHS) has decided to
temporarily suspend a ban on mercury-based flu vaccines given to
children under three, citing a vaccine shortage caused by
production delays.
Merck Sharp & Dohme has just announced a €100m investment in
South Tipperary, Ireland to build a new formulation R&D centre
and drug manufacturing plant.
IntegraGen has made significant waves in the area of personalised
healthcare announcing a collaborative with the DSM Personalised
Nutrition Group and a €2m equity investment by DSM Venturing.
The University of Minnesota for drug design has been awarded a
$2.5m, 5-year grant by the National Institute of Health (NIH) to
research antidotes for cyanide poisoning, improving on current
antidotes that are slow acting.
According to a new report the advent of genetic technologies for
biomarker discovery and drug development is having a positive
knock-on effect for qRT-PCR products, as this technology has given
new hope to the search for biomarkers...
Plastic labware manufacturers Nalge Nunc have launched its range of
RNase/DNase-free products and capabilities specifically designed to
support molecular biology research from microwell plates to
packaging.
Researchers have developed a more efficient and cost-saving method
to make cladribine, a drug used for the treatment of certain types
of leukaemia and potentially efficient against multiple sclerosis
(MS).
Massachusetts-based Millipore has reported a fall in net profit in
its third quarter results, mainly due to increased costs and recent
acquisition charges.
Genomics-based drug discovery company Galapagos, has struck a deal
with LEO Pharma in an agreement that will see the firm use its
natural compound collection for high throughput screening, hit
verification, and profiling of selected...
The acting US FDA commissioner has given his endorsement to human
microdosing studies for drug development in a show of backing that
indicates the Agency is open to receive Exploratory IND
applications to accelerate drug development.
The contract sales and marketing business will reach $5.2bn (€4bn)
by 2011, as it represents an ideal outsourcing opportunity for
pharma companies competing in this fast growing sector, according
to new market research.
Canadian drug maker LAB International has announced its plan to
acquire Texan PharmaForm in order to speed up the manufacture of
its inhalable anti-pain drug, which will reach late stage clinical
trials next year.
Scientists are looking into the possibility of using bacteria to
make a new library of anti-cancer compounds that are usually too
difficult to create synthetically. The discovery could provide the
basis for developing useful new anti-cancer...
Roche took the opportunity at the American Association for the
Study of Liver Diseases (AASLD) meeting to disclose the results of
its hepatitis C polymerase inhibitor, which exhibited viral
reductions greater than current polymerase...
According to the international medical humanitarian organisation
Médecins Sans Frontières (MSF), the World Health Organisation (WHO)
has failed to address the emergence of extensively drug-resistant
(XDR) tuberculosis.
French pharma company Servier has announced the launch of a new
manufacturing facility and also the expansion of its existing
operation in Ireland, an investment totalling €184m.
Sigma-Aldrich launches the first commercially available proteomics
standard in which allows researchers to better assess proteomics
strategies, troubleshoot protocols and normalise results from day
to day and lab to lab.